Towards medicines reuse: a narrative review of the different therapeutic classes and dosage forms of medication waste in different countries by Alhamad, Hamza et al.
Towards medicines reuse: a narrative 
review of the different therapeutic classes 
and dosage forms of medication waste in 
different countries 
Article 
Published Version 
Creative Commons: Attribution 4.0 (CC-BY) 
Open Access 
Alhamad, H., Patel, N. ORCID: https://orcid.org/0000-0002-
8600-0663 and Donyai, P. ORCID: https://orcid.org/0000-
0001-5403-6170 (2020) Towards medicines reuse: a narrative 
review of the different therapeutic classes and dosage forms 
of medication waste in different countries. Pharmacy, 8 (4). 
230. ISSN 2226-4787 doi: 
https://doi.org/10.3390/pharmacy8040230 Available at 
http://centaur.reading.ac.uk/94709/ 
It is advisable to refer to the publisher’s version if you intend to cite from the 
work.  See Guidance on citing .
Published version at: https://www.mdpi.com/2226-4787/8/4/230 
To link to this article DOI: http://dx.doi.org/10.3390/pharmacy8040230 
Publisher: MDPI 
All outputs in CentAUR are protected by Intellectual Property Rights law, 
including copyright law. Copyright and IPR is retained by the creators or other 
copyright holders. Terms and conditions for use of this material are defined in 
the End User Agreement . 
www.reading.ac.uk/centaur 
CentAUR 
Central Archive at the University of Reading 
Reading’s research outputs online
pharmacy
Review
Towards Medicines Reuse: A Narrative Review of the
Different Therapeutic Classes and Dosage Forms of
Medication Waste in Different Countries
Hamza Alhamad 1,2,* , Nilesh Patel 1 and Parastou Donyai 1
1 Department of Pharmacy, University of Reading, Reading RG6 6AP, UK; nilesh.patel@reading.ac.uk (N.P.);
p.donyai@reading.ac.uk (P.D.)
2 Department of Pharmacy, Zarqa University, 132222 Zarqa, Jordan
* Correspondence: halhamad@zu.edu.jo
Received: 2 September 2020; Accepted: 27 November 2020; Published: 1 December 2020 
Abstract: Background: Medicines reuse, the idea of re-dispensing returned medicines to others
following quality control, is yet to be implemented in the UK. This practice is potentially a sustainable
way of dealing with returned medicines, which are otherwise classed as medication waste
and destroyed. To inch towards medicines reuse, it is important to know more about the different
therapeutic classes and dosage forms that make up medication waste. For example, it is helpful to know
if medicines being returned are mostly solid-dosage forms and thus have the potential to be reused or
are from therapeutic classes that would make medicines reuse cost-effective. Little is known about
the therapeutic classes and the dosage forms of wasted medicines. This study aimed to narratively
review and report findings from the international literature on the different therapeutic classes and
the dosage forms of medicines that are returned by patients to community pharmacies, hospitals,
general practitioners’ clinics, or collected through waste campaigns. Studies based on surveys without
physically returning medicines were also included where relevant. Methods: A comprehensive
electronic search of databases, including PubMed and Google Scholar, was carried out over one
month in 2017 and updated by 5 November 2020, using a combination of carefully created keywords.
Results: Forty-five studies published in English between 2002 and 2020, comprising data from
26 countries were included and reviewed. Oral solid dosage forms (mostly tablets) were the
commonly reported dosage form of all wasted medicines in 14 studies out of the 22 studies (64%) that
described the dosage form, with percentages ranging from 40.6% to 95.6% of all wasted medicines.
Although there was variability among the levels of medication waste reported in different countries,
findings from the UK and Ethiopia were relatively consistent; in these, medicines for the cardiovascular
system and anti-infective medicines, respectively, were the most common therapeutic classes for
medication waste. Conclusion: This narrative review provides insights about the different therapeutic
classes and dosage forms of medication waste either returned by patients, collected through waste
campaigns, or indicated in survey responses. The findings could help policy makers understand the
potential implications of treating most unused medicines as medication waste and whether therefore
pursuing a medicines reuse scheme could be environmentally or financially logical. The quality and
the safety of these returned medicines using criteria related to the storage conditions (such as heat
and humidity), physical shape (such as being sealed, unopened, unused, and in blister packaging),
and tampering are other important considerations for a medicines reuse scheme.
Keywords: medicines reuse; medication waste; therapeutic class; dosage form; sustainability;
waste management
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1. Introduction
Waste can be referred to as any substance or object the holder discards, intends to discard,
or is required to discard [1]. The World Health Organisation (WHO) defines pharmaceutical or
medication waste as “expired, unused, spilt, and contaminated pharmaceutical products, drugs,
vaccines and sera” [2]. Medication waste is a growing problem in the UK and different parts of the
world in terms of its negative impact on governmental expenditures, the environment, and human
health [3–7]. Waste associated with prescribed medicines cost the National Health Service (NHS)
in England an estimated £300 million a year in 2009, £110 million of which related to medicines
returned to community pharmacies for disposal [6]. However, the financial cost is only one part of the
medication waste burden. The negative impact on the environment is also significant with one reason
for finding pharmaceuticals in the water environment [7] being the improper disposal of medication
waste [8,9]. The presence of medication waste in the environment can modify the physiological function
of living creatures and has been linked to the possible emergence of antibiotic-resistant bacteria such
as vancomycin-resistant enterococci and beta-lactam-hydrolysing Enterobacteriaceae [10], as well as
the feminising effects of endocrine deactivating compounds such as ethinyl estradiol [11]. The risk to
human health is not limited to pollution and contamination of the drinking water, as there is also a risk
when others in the home consume unused medicines that have been stockpiled but ought to have
been dealt with safely. For example, patients might self-medicate for a new illness with medication
previously prescribed for a different illness, causing harm through misdiagnosis or mistreatment [12];
there might be accidental poisoning if children use stockpiled medicines; and medicine abuse might
occur where the medicines are controlled or have addictive properties [13].
The causes of medication waste are divided into preventable (e.g., patient stockpiles medicines,
overprescribing, or repeat dispensing of unwanted medicines), non-preventable (e.g., death of
a patient, or a change in the prescription meaning the previous medicines are no longer required)
and non-adherence behaviours [1,6,14]. Therefore, prevention is one way to reduce medication waste.
Preventing waste is in fact the top option according to the Waste Hierarchy, which is a grading
framework that ranks waste management options according to what is best for the environment,
with “prepare for reuse”, “recycle”, “other recovery”, and “disposal” following “prevention” in
decreasing preference order [15]. Many interventions have been attempted to prevent medication
waste, but these have not always been effective, as the most common causes of medication waste are
actually non-preventable [14]. Medicines reuse—the idea of re-dispensing returned medicines to others
following quality control—is an underexplored concept in the UK but could help reduce medication
waste regardless of the cause. What is more, qualitative studies have previously analysed intentions
and actions towards the reusing of medication waste, reporting a possible future for the idea [16–19].
Numerous factors influence the practicalities of such an idea, including the prior storage conditions,
as well as the therapeutic classes and the dosages forms of medicines considered to be waste but
which might then be reused. Knowing information about the different therapeutic classes and dosage
forms of medication waste creates some understanding of which medicines might potentially be up for
reuse. For example, it is helpful to know if medicines being returned are mostly solid-dosage forms
(thus having the potential to be reused), or liquids, injectables, etc., and whether these medicines are
over the counter (cheaper/not critical to NHS costs) or other therapeutic classes that could be more
relevant in terms of environmental sustainability or cost-effectiveness.
Despite a thorough literature review on the causes of medication waste [6,14,20–23],
the financial [4,6,20,24–28] and environmental impact of medication waste [7,10,11], medicine disposal
practices [8,9,22,24,28–34], and management strategies of medication waste [6,14], only some studies
have reported the type and therapeutic classes and dosage forms of unused or returned medication waste,
and none have brought the information together in a focused review [6,23,28]. This study aimed
to narratively review and report findings from the literature about the different therapeutic classes
and the dosage forms of medication waste that are returned by patients to community pharmacies,
hospitals, general practitioners’ clinics, or collected through waste campaigns in different countries
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around the world. Results from studies based on surveys (without the physical return of medicines)
were also included to take account of relevant data collected via this alternative method.
2. Materials and Methods
A search of electronic databases was carried out over one month in 2017 and updated in 2020 ending
on 5 November 2020 to identify reports and studies published in English detailing therapeutic classes
and dosage forms of medication waste. Electronic databases searched comprised PubMed/Medline,
Cochrane library, Grey literature (open grey and British library), National Audit Office (NAO),
and National Institute for Health and Care Excellence (NICE) evidence. The bibliographies of retrieved
references were also searched.
The search activity used combinations of a list of terms that included the following: types of
unused medicines OR classes of unused medicines OR dosage forms of unused medicines OR types of
medicine waste OR classes of medicine waste OR dosage forms of medicine waste OR types of unused
drugs OR classes of unused drugs OR dosage forms of unused drugs OR types of drug waste OR
classes of drug waste OR dosage forms of drug waste.
The inclusion criteria aimed to select studies published in English that reported the therapeutic
classes and dosage forms of returned medication waste, either dispensed following a prescription or
purchased over the counter (OTC), or a medicine sample that had expired (or had no clear expiry date)
or was never fully consumed (or not used at all). Studies describing medical waste, medical device
waste, and/or clinical tissue waste were excluded.
Study selection was completed by two researchers (H.A. and N.P.) using a Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA) flow of identification, screening, eligibility,
and inclusion [35] (Figure 1). At first, 3390 candidate studies were identified; then, 18 duplicates
were removed. All study titles and abstracts of the remaining 3372 studies were screened,
with 3311 studies removed, resulting in 61 potentially eligible studies. After a thorough full-text
review of the 61 studies to assess for eligibility, 45 studies published between 2002 and 2020 were
included in this narrative review. Data obtained from the retrieved studies described demographic
information of the participants, the types and dosage forms of medication waste, study settings and
sample size, and the time/duration of the collection of the returned medicines (varying from 4 weeks
up to 12 months).
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3. Results
The search yielded 3390 candidate studies. A total of forty-five studies published between
2002 and 2020 and comprising data from 26 different countries from around the world (Australia,
Austria, Egypt, Ghana, India, Jordan, Kuwait, Malaysia, Mexico, New Zealand, Oman, Qatar,
Saudi Arabia, Spain, Taiwan, Tanzania, Thailand, United Arab Emirates, United Kingdom,
United States of America, China, Malta, Indonesia, Iraq, Nigeria, and Ethiopia) were included
and reviewed. In some of these studies, medication waste was returned by patients to community
pharmacies, general practitioners’ clinics, hospitals or sometimes collected via medicine take-back
and medicine waste campaigns. However, twenty nine (the majority) studies used a survey to collect
information about the therapeutic classes and dosage forms of medication waste by asking participants
for information without physically collecting the waste: six studies from Ethiopia [36–41], three from
India [42–44], two from Malaysia [24,45], two from the USA [34,46], two from Jordan [47,48], two from
Egypt [26,49], two from Thailand [20,50], one from Qatar [51], one from China [52], one from Iraq [53],
one from Indonesia [54], one from Nigeria [55], one from Spain [56], one from Saudi Arabia [27], one
from Tanzania [57], one from Malta [58], and one from Ghana [59]. The methodologies used and the
targeted populations are summarised in Appendix A Table A1.
3.1. Studies’ Samples
The studies’ samples were reported in different ways. Most studies reported sample size as the
number of medication waste items returned or collected. Other studies reported the sample as per
weight (kg), per bag, packs, or containers of the collected returned medication waste. The sample for
survey-based studies was reported as the number of completed questionnaires collected or the number
of participants surveyed. For more details about the sample of the studies included, please refer to
Appendix A Table A1.
3.2. Demographics of the Participants
Gender was not reported in the majority of the studies (Appendix A Table A1). Fifteen studies
(36% of the retrieved studies) described the gender of the participants, and it was not apparent that
there is a gender difference associated with the presence/reporting of medication waste. For example,
more women took part in seven of the studies [20,38,45,52,54,56,57] and more men took part in eight of
the studies [36,37,39,40,42,49,55,59]. In the study from Egypt [49], the number of people who returned
their medication waste happened to be more male than female and one study from Malaysia [24]
recruited female students only.
Age of participants was described in 23 studies out of 45 studies (51%) (Appendix A Table A1).
Participants’ age profile varied in these studies and was up to 81 years. Twelve studies of the 23 studies
(25%) found an apparent relationship between the mean number of returned medicinal items per
patient and their age. Here, the majority of medication waste was reported to be from participants
with the age ranges of 60–80 years [21,31,32,49,57]. Two studies [43,59] had more data relating to
participants in the age range 20–40, but this was an artefact of the study designs, focussing on students
who are likely to be in that younger age range. It is not possible to conclude that the age range of
60–80 years was associated with more medication waste as, additionally, age data was absent from half
of the studies (49%).
3.3. Dosage Forms of Returned Medication Waste
Dosage forms were investigated in 22 out of the 45 studies (49%) on medication waste
(Appendix A Table A2). Dosage forms included a range of oral solid dosage forms (tablets, capsules,
granules, powders, and lozenges), liquids (syrups, injections, eye drops, suspensions, emulsions,
and lotions), semisolids (ointments, creams, gel, paste and suppositories), and other items such as
inhalers, sprays, patches, strips, and chewing gum. Oral dosage forms were the most commonly
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reported formulation in fourteen studies out of 22 (64%) with percentages ranging from 40.6% to
95.6% of all medication waste. Moreover, tablets were reported to be the most common of the oral
dosage forms.
One study from Oman (60) reported that during handling of the dosage forms, most of them
appeared in a suitable condition for reuse and were still in their original container. However, some had
changed in colour, consistency, and odour and therefore were deemed not to be suitable for reuse.
Results from a UK study [36] were consistent with the Oman study [60] in which many of the returned
medication waste items were reported to be in a condition suitable for reuse as assessed by a pharmacist.
These were the only two studies that directly commented on whether the medication waste returned
was potentially suitable for reuse.
3.4. Therapeutic Category of the Returned Medication Waste
Except for two studies [31,57] in which only prescribed medicines were included in the authors’
analysis, the majority of the studies include both prescribed and OTC medicines. Moreover, only three
studies [25,26,61] included medicinal samples in addition to prescribed and OTC medicines.
The majority of the studies (42 out of the total 45) reported the therapeutic category of the medication
waste, and these were included in the current analysis (Appendix A Table A2). The remaining three
studies reported the medication waste individually by generic or brand name and were therefore
excluded from the current analysis.
The therapeutic categorisation systems used for reporting the findings were not the same in all studies.
Seven studies used the British National Formulary (BNF) categories [6,26,49,60,62–64]. Seven studies
used the Anatomical Therapeutic Chemical Coding (ATC) of the WHO [33,36,48,56,58,65,66].
Other ways of therapeutic categorisation included national codings such as the Saudi National
Formulary (SNF) [27], Chinese Pharmacopoeia [52], and the Monthly Index of Medical Specialities
online (MIMS) [20]. The remaining studies used disease and class of medicine classification such
as diabetes/anti-diabetic. A breadth of therapeutic categories reported included cardiovascular
system (CVS), central nervous system (CNS), alimentary tract/gastrointestinal tract (GIT),
respiratory system, musculoskeletal system and joint disease, analgesics and antipyretics, non-steroidal
anti-inflammatory drugs (NSAIDs), endocrine system, malignant disease and anticancer medicines,
nutrition and blood, vitamins and minerals, gynaecology and medicines for urinary tract infection (UTI),
antibiotics, medicines for ear, nose, and oropharynx, and skin medicines.
Eight studies out of the 42 (19%) reported that CVS medicines were the most common therapeutic
category of medication waste [6,32,49,60,62–64,66]. Similarly, eight studies out of 42 (19%) reported that
anti-infective medicines were the most common therapeutic category of medication waste [26,36–41,57].
CNS medicines were reported in five studies out of the 42 (12%) as the most common therapeutic
category of medication waste [21,31,47,51,65].
The different therapeutic categorisation systems used in reporting medication waste (sometimes
in studies completed in the same country) make the interpretation of results difficult. For example,
two studies, one from India [42], and one from the USA [25], combined analgesics with nonsteroidal
anti-inflammatory drugs (NSAIDs) into one therapeutic category, while five studies from India [43],
the USA [34,46], Mexico [61], and Thailand [50] described analgesics and antipyretics as one category
and musculoskeletal and joint disease medicines as another category. In addition, the number of studies
that investigated medication waste by therapeutic categorisation was more likely to be from a small
number of countries. For example, seventeen studies out of forty-two (40%) were from four countries:
the UK [6,13,62,64], Ethiopia [36–41], New Zealand [21,31,65,67], and the USA [25,34,46]. This makes
reporting of the results by the number of studies less representative of the international literature.
Therefore, in order to synthesise the results for this narrative review, all the different therapeutic
categories were re-classified according to the BNF categorisation system and then represented by
country (Figure 2). For example, NSAIDs were re-classified under musculoskeletal system medicines
(BNF Chapter 10), analgesic and antipyretics were re-classified under CNS medicines (BNF Chapter
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4), and alimentary tract system medicines were re-classified under gastrointestinal system medicines
(BNF Chapter 1). In addition, in countries where more than one report was found, such as the Ethiopia,
UK, New Zealand, Jordan, and Egypt, the sum of all returns of medication waste was calculated and
reported by country.
Figure 2 shows the results of the common therapeutic categories of medication waste reported
by country and after re-classification according to the BNF categorisation system. In the UK,
CVS medicines were the most common therapeutic class of medication waste, with CNS medicines
being the second most common therapeutic class. Other therapeutic categories of medication
waste, such as gastrointestinal and respiratory medicines, were also reported but less commonly in
the UK. Similar results to the UK were reported from countries such as Australia, Austria, Mexico,
and Oman where CVS medicines were the most common therapeutic class of medication waste.
Moreover, in Mexico, Australia, and Austria, musculoskeletal system medicines were also common
and the second most reported category.
In New Zealand, CNS medicines were the most common therapeutic class of medication waste.
Other therapeutic categories such as gastrointestinal, cardiovascular, and musculoskeletal system
medicines (with diclofenac sodium and ibuprofen reported to be commonly returned as waste) were
also reported in studies from New Zealand but less than CNS medicines. In Jordan and Qatar,
results were similar to New Zealand, where CNS medicines were the most common therapeutic
class of medication waste. In Jordan and Qatar, paracetamol was the most common individual tablet
considered as waste. In addition, in Jordan, gastrointestinal medicines were reported as the second
most common therapeutic class of medication waste followed by anti-infective medicines. In Qatar,
anti-infective medicines were reported as the second most common therapeutic class of medication
waste. Other therapeutic categories of medication waste such as musculoskeletal system medicines
were reported in Jordan and Qatar but less commonly.
In Spain, both the gastrointestinal system and CNS medicines were the most common therapeutic
classes of medication waste. In Taiwan, gastrointestinal system and CVS were the most common
therapeutic classes of medication waste. While in Saudi Arabia, both the respiratory system and CNS
medicines were the most common therapeutic classes of medication waste.
In Ethiopia, Egypt, and Tanzania, anti-infective medicines were the most common therapeutic class
of medication waste. The CNS medicines (in Ethiopia), and CVS medicines (in Egypt and Tanzania)
were reported as the second most common therapeutic class of medication waste. Other therapeutic
categories of medication waste such as musculoskeletal and gastrointestinal system medicines were
reported in Ethiopia, Egypt, and Tanzania, but less so.
Studies from the USA, Thailand, India, and Indonesia showed that musculoskeletal system
medicines were the most common therapeutic class of medication waste in these countries.
Finally, in Malaysia, vitamins and minerals were the most common therapeutic category of
medication waste.
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4. Discussion
Despite the extensive literature on medication waste, no literature review to date had explicitly
focused on the therapeutic classes and the dosage forms of medication waste items. This narrative review
addresses that gap. The principal finding is that CVS (certainly in the UK) and anti-infective (certainly
in some African countries) medicines are reported as some of the most commonly returned/accumulated
medication waste category. Arguably, knowing the therapeutic category of medication waste is as
crucial as the quantity of the returned medication waste in terms of environmental and financial
potential for medicines reuse. This is because medicines in certain therapeutic categories cost more.
For example, one UK study [63] reported the volume of waste relating to respiratory system medicines
to be about half (8%) that reported for CNS medicines (19%), but the cost of the medicines in the
respiratory group was about the same as those in the CNS category. Thus, knowing the therapeutic
categorization of medication waste makes it easier to judge where medicines reuse might be financially
logical. It is of course essential to quality assure the safety of any returned medicines using criteria
related to the storage conditions (such as heat and humidity), physical shape (such as being sealed,
unopened, unused, and within blister packs), and tampering. Two studies conducted in Oman [60] and
the UK [63] directly commented on whether the medication waste returned was potentially suitable
for reuse. These studies reported that during handling of the dosage forms, most of the returned
medicines appeared in a suitable condition for reuse and were still in their original container, with only
a few having changed in colour, consistency, and odour; thus, these were deemed unsuitable for reuse.
Findings of these studies are also important considering that unused medicines from the so-called
developed world are sometimes sent for reuse to so-called developing countries.
In the UK, CVS medicines were the most common therapeutic class of medication waste.
A possible explanation is that CVS medicines are one of the commonly prescribed medicines in
the UK, comprising approximately 20% of all the medicines prescribed because of the prevalence
of cardiovascular disease. Moreover, CVS medicines are one of the commonly amended classes of
medicines because of frequent changes in doses and drugs necessitated by guidelines [62]. In Ethiopia,
Egypt, and Tanzania, anti-infective medicines were the most common therapeutic class of medication
waste. This is possibly because antibiotics have been available without a prescription in these
countries, where also it is common for people not to complete their course of antibiotic treatment
when their symptoms resolve. In New Zealand and Jordan, CNS medicines were the most common
therapeutic class of medication waste with paracetamol as the most common individual tablet returned
as waste. The potential explanation here is that analgesics (with paracetamol reported to be the most
common) are frequently used for the self-medication of headaches, which is a commonplace discomfort.
Similarly, in the USA, Thailand, and India, the musculoskeletal system medicines were the most
common therapeutic class of medication waste with NSAIDs being the most common group reported
in these countries, again reflecting their common usage. In the study from Malaysia, vitamins and
minerals were reported as the most common therapeutic category of medication waste, but this is
likely an artefact of the methods, which only sampled female students.
This narrative review synthesised information about the most commonly found medication waste
products from different countries around the world. However, the results should be interpreted carefully.
First, the findings apply to medication waste that was returned by patients only or reported in surveys
and does not take into account the substantial amount of medication waste likely to be disposed of into
household garbage or via the sink or simply kept stockpiled unreported at home [65]. Second, the small
sample size and the small number of returns of medication waste in the majority of the studies made
these studies less likely to be representative of a global picture. Third, the CNS classification of
paracetamol as the most commonly reported item as waste raised the percentages of waste from the
CNS therapeutic class compared to other therapeutic classes such as musculoskeletal, alimentary tract,
and respiratory systems. Paracetamol is considered cheap, and one may argue that it is not worthwhile
to set up a medicines reuse system if this is the largest category of returned medicines in any one
country. Fourth, the quality of the studies included in this narrative review was not checked because
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of the disparity of methods and a lack of specific criteria, which could affect the results reported
(as none of the papers found were excluded) and could be seen as another limitation of this study.
Finally, the results of this narrative review cannot be generalised. For example, results from Ethiopia,
Egypt, and Tanzania of having antibiotics as the most common therapeutic category of medication
waste cannot be generalised (although reported to be the commonest along with CVS medicines) to
other countries where antibiotics are only available with a prescription such as in the UK or the USA.
In addition, results from the two Malaysian studies, which reported that vitamins and minerals were
the most common therapeutic category of medication waste, is impossible to generalise to the larger
population, as one study was only completed with female Malaysian students (no males). The other
Malaysian study was also completed by more females than males.
This narrative review has other limitations that should also be acknowledged. First, it included
results from reports, theses, audits, and the grey literature, but there is always a risk that some studies
were not included as a result of not performing a thorough enough systematic search. Second, the search
strategy was restricted to studies that were published in the English language only and so could have
missed other valuable research. Third, the reasons behind the accumulation of the returned medication
waste from each therapeutic category were not clearly evidenced in all the studies. Some studies
provided possible explanations that may apply only to the country from which data were obtained,
and therefore, it may not be appropriate to generalise these explanations. Finally, information about
what motivates people to return their medication waste and if they returned a certain type of medication
waste over others were not investigated and remain unknown.
This review is the first to provide narrative information about the different therapeutic categories
and dosages forms of returned medication waste from different countries around the world.
Pooling information about the different therapeutic classes and dosage forms of medication waste can
help increase knowledge about medicines that are returned unused and or otherwise classed as wasted
medicines, so that extrapolations can be made about the costs of waste and whether it is worthwhile to
reuse these medicines. For example, paracetamol is considered cheap, and one may argue that it is not
worthwhile to set up a medicines reuse system if this is the largest category of returned medicines
in any one country. In addition, oral solid dosage forms are more likely to be suitable candidates for
reuse compared to other dosage forms such as liquids or injectables; therefore, it is useful to know
where this is the most commonly returned formulation. However, a pharmacist’s hand inspection
of such medicines would not be sufficient to address concerns about the quality and the safety of
returned medicines. For example, there would also need to be additional checks in place for storage
conditions (e.g., under excessive heat and humidity), and physical characteristics (such as being sealed,
unopened, unused, and being in a blister) which could indicate (non-)tampering, degradation or
contamination, in addition to the visual indicators. These concerns would need to be addressed before
medicines reuse becomes a reality [23,68], and one way to do this would be through the application of
technology [69,70].
This narrative review identified a large number of studies from the literature that investigated
the different therapeutic classes and the dosage forms of medication waste returned by patients
to healthcare settings, and through waste campaigns, as well as information obtained from
survey responses. Although there was variability among the levels of medication waste reported in
different countries, findings from some countries such as the UK and Ethiopia were relatively consistent
and appeared to reflect the local usage of these medicines. This suggests that medication waste
categories might be proportional to the prevalence of medicines in each specific country, which remains
to be tested in future studies. Future studies that focus on assessing the quality and the safety of
retuned medicines, and exploring public and healthcare providers’ perception about medicines reuse
should also be performed before medicines reuse becomes a reality. For example, contained sites
such as long-term care facilities or hospice care settings where the medications are presumably stored
correctly might be more capable of reusing medicines and could be a realistic site for trialling medicines
reuse in the future.
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5. Conclusions
Findings from this narrative review provide insight about the different dosages forms and the
therapeutic classes of medication waste, which can be used to support future medicines reuse-related
research and explorations. It appears that the therapeutic categories of medication waste are reflecting
prevalence of usage, inviting policy makers in each country to reflect on whether medicines reuse
could be cost-effective in their own settings. Any medicines reuse scheme would still need to consider
quality and safety checking of returned medicines over and above the pharmacists’ visual checks.
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Appendix A
Table A1. Summary of the research instrument, sample, and demographics of the included studies.
Year of Study Author(s) Country/Settings Research Instrument
Wasted Medicines
Information (e.g., Take Back
Campaigns vs. Survey)
Sample Demographics
2015 Gracia-Vásquez et al. [61] Mexico; nine citiesof Monterrey
Unused/expired medications were collected
from households in a special container
placed in a visible and accessible location in
85 collection centres in community
pharmacies located in nine cities in the
Monterrey metropolitan area over 12
months from March 2012 to February 2013
Take back program.
Random sample of 22,140
items, 30% of total drugs
collected over 12 months),
as 70% were unable to
be classified.
Not studied.
2008 Braund et al. [21] New Zealand
Over a five-week period medications were
returned to two collection point pharmacies
and questionnaires were completed by
returners.
Take back program.
In addition, a questionnaire
was completed to determine
the reasons that the
medications were not used.
163 returns, comprising of
1399 items, with only 126
returned questionnaires.
The majority of those
returning medications fall
within the age range of
61–80 years.
2007 Braund et al. [67] New Zealand;Otago Pharmacies
Medications returned unsolicited to Otago
pharmacies over a 9-month period, from 1
April to 31 December 2005.
Take back program.
A random sample (159 kg, 12%)
of the 1294 kg of medications
returned for destruction over
a nine-month period from the
Otago region were identified.
Not studied.
2009 Braund et al. [31]
New Zealand; Hutt
Valley District Health
Board
A Disposal of Unwanted Medication
Properly (DUMP) campaign was conducted
for 4 weeks in November 2007 in 31
community pharmacies. Questionnaires
were completed by the returners.
Take back program.
‘Disposal of Unwanted
Medication Properly
(DUMP)’ campaign.
Of the total 1605 bags returned
over 4 weeks for disposal,
only 329 bags (20%),
containing a total of 1253 items
were fully analysed. Only 653
questionnaires were
completed (41%).
The age distribution of
the patients with unused
medications was
<20 (8%), 21–40 (13%),
41–60 (28%), 61–80 (40%)
and >81 years (11%).
2010 Caroline et al. [29] New Zealand;Nelson Bays region
A Disposal of Unwanted Medication
Properly (DUMP) campaign was conducted
for 5 weeks in November and December
2009 and for 3 weeks afterwards. Surveys
were completed in 379 bags.
Take back program.
‘Disposal of Unwanted
Medication Properly
(DUMP)’ campaign.
Of the 6500 DUMP bags
distributed across the Nelson
Bays region, 1244 bags were
returned (response rate 19%),
with an average of 7 items per
bag (number of items
returned 8609).
Not studied.
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Wasted Medicines
Information (e.g., Take Back
Campaigns vs. Survey)
Sample Demographics
2009 James et al. [65]
New Zealand:
Taranaki region
(around 37,000 households)
Unused medications returned for disposal
to the 24 community Pharmacies in the
Taranaki region (≈37,000 households) of
New Zealand over 6 weeks.
Take back program.
716 individuals returned 3777
items of unused medications.
Of the 3777, information for the
amount issued and returned
was complete for 2704.
The majority (51%) of returns
contained 75–100% of the
original dispensed amount
of medication.
Not studied.
2005 Langley et al. [62] United Kingdom;East Birmingham
Unused medications returned to
8 community pharmacies and 5 general
practices (G.P.) surgeries over 4 weeks each
(4 weeks during August 2001, 4 weeks
during March 2002, respectively).
No return campaign was
conducted and no attempt
was made to encourage
patients or carers into
returning medicines.
Medicines returned to
8 community pharmacies
and 5 general practices (G.P.)
surgeries over 4 weeks
were assessed.
A total of 114 returns;
24 (21.1%) to G.P. surgeries and
90 (78.9%) to community
pharmacies. The total returns
comprised 340 items, of which
42 (12.4%) were returned to
G.P.s and 298 (87.6%) to
community pharmacies.
Older patients (60 years
and over) returned 61.4%
of items with 24.6% of
returns coming from
patients aged 30–59 years
and 5.3% of returns
originating from patients
under 30. Ages were not
recorded for 8.7%
of returns.
2007 Mackridge et al. [63]
United Kingdom; Eastern
Birmingham Primary
Care Trust (P.C.T.)
Unused medications returned to pharmacies
and G.P. surgeries were collected over 8
weeks in May and June 2003 in Eastern
Birmingham Primary Care Trust (P.C.T.).
Three-quarters of the P.C.T. sites
participated, 51/60 (85%) pharmacies and
42/61 (70.5%) G.P. surgeries.
Unused medicines were
returned and data were
collected in Eastern
Birmingham Primary Care
Trust (PCT), a predominantly
urban PCT with an ethnic
minority population of 20%.
934 return events were made
from 910 patients (190 GP
surgeries, 744 pharmacies),
comprising 3765 items (431 GP
surgeries, 3334 pharmacies)
and totalling 4934
individual packs.
The mean age of
63.5 ± 0.78 years
(10 months to 99 years)
and there was no
detectable correlation
between the mean
number of items returned
per patient and their age.
2008 Bradley [64] United Kingdom;Cumbria
A medicine waste audit in community
pharmacies of Cumbria where each
pharmacy asked to analyse 20 returns of
unused medicines. Further qualitative data
were collected by interviewing the patients
and their representatives.
Unused medicine were
returned to community
pharmacies in Cumbria
where each pharmacy was
asked to analyse 20 returns of
unused medicines.
A total 4563 items was received
from 87 community
pharmacies across Cumbria.
Not studied.
2010 Trueman et al. [6] United Kingdom
Unused medications returned to 114
pharmacies (51 from London/urban, 32 from
North-West/rural and urban, 24 from
Yorkshire and Humber/rural and urban,
7 from West-Midlands/rural) from 5 primary
care trusts.
Unused medicine were
returned to 114 pharmacies
in 5 primary care trusts.
In total, 8626 items were
reported as returned with 7500
of the returned items identified
and coded for analysis.
Not studied.
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Campaigns vs. Survey)
Sample Demographics
2008 Coma et al. [56] Spain; Barcelona
Unused medications returned to random
sample of 118 community pharmacies in
Barcelona invited to participate, 38 (32%)
agreed to participate. Data were collected
from February to April 2005. Questionnaires
were completed by the returners.
Unused medications were
collected from 38 community
pharmacies over a period of 7
consecutive working days
(excluding Sundays).
A questionnaire was
designed to evaluate each
returned medicine.
In total, 1176 packages were
returned by 227 patients.
The majority were medicines
(96.6%), and the rest were
medical supplies or devices
(0.5%) or other products sold in
the community pharmacy
(2.9%; e.g., personal care,
nutrition). Most medicines
returned were drugs for
human use (99.8%) and only
0.2% were for veterinary use.
54.6% women, 64 ± 20
years old.
2015 Law et al. [46] U.S.A.; SouthernCalifornia
Cross-sectional, observational two phases
study was conducted using a convenience
sample in Southern California. In Phase I,
a web-based survey was conducted at one
health sciences institution; and in Phase II,
a paper-based survey at drug take
back events.
Web and paper-based survey.
Phase I: A total of 539
prescription medications were
reported, with an average of 4
per household. Approximately
7% of the unused medications
were expired, and 30% were
brand name.
Phase II: Of the 776 unused
medications returned for
disposal, 311 (40%)
medications were brand name.
Nearly two-thirds (66.2%) were
expired, discontinued by the
physician (25%), or became
unused after the patient
indicated feeling better (17.6%).
Phase I: Average
household age was
36.4 years, but not
described in Phase II
which the drug take back
program.
2004 Garey et al. [25] U.S.A.; Houston, Texas
Unused medications returned to community
pharmacy during “Medicine Cabinet
Clean up
Campaign” over 6 months between April
and September 2002 (pilot study).
“Medicine Cabinet Clean up
Campaign”
In total, 1315 medication
containers were returned to the
community pharmacy. 63% of
returned medications were
dispensed between 2000 and
2002, 31% from 1995 to 1999,
and 6% before 1995.
Not studied.
2015 Maeng et al. [34]
U.S.A.; Regional health
plan in Central
Pennsylvania
Telephone survey conducted by a survey
research centre. Telephone survey. Not studied. Not studied.
2014 Vogler et al. [66] Austria; Vienna
Unused medications collected from
household garbage in all districts of Vienna
between 12 October and 24 November 2009.
Unused medicines ending
up in household garbage
were analysed in all districts
of Vienna.
In total, 152 packs were
identified from manually
investigated sample from
household garbage in Vienna.
Not studied.
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2013 Chien et al. [71]
Taiwan; Shuang-Ho
university teaching
hospital
Discarded drugs were collected from the
Drug Discarding Bin at the Shuang-Ho
Hospital over 4 weeks.
Discarded drugs from the
Drug Discarding Bin at the
Shuang-Ho Hospital in
Taiwan were collected and
analysed. A paper-based
questionnaire was utilised to
study the attitudes and
perspectives of the
out-patients and/or patients’
family members about
discarding unused
medications that were
prescribed and covered by
the National Health
Insurance policy.
A total of 98 kg (51,972)
discarded medications
collected from the hospital
Drug Discarding Bin.
Not studied.
2013 Abushanab et al. [48] Jordan; Amman
Cross sectional survey using a pre-piloted
questionnaire was used in the interview of
219 households in 9 areas of Amman to
about the types of drugs stored at home
conducted between November 2009 and
April 2010.
Survey study.
From the 2393 drug products
presented in surveyed
households, 24.99% was
considered as drug waste (drug
wastage, calculated as the sum
of drug products that had
expired 10.91%, had no clear
expiration date 1.84%, or which
had never been used since
dispensing 15.04%).
Age of the interviewee
(years) 42.15 ± 14.67.
2012 Al-Azzam et al. [47] Jordan; North of Jordanparticularly Irbid
Validated questionnaire was administered
to 435 households selected randomly from
different areas in the north of Jordan
(particularly in Irbid governorate) in the
period from April 2007 and until August
2007.
Survey study.
Of the total of 2835 medication
items found in the 435 selected
houses, 65.3% were in use, and
34.7% were not in use.
Age of the interviewee
(years) 36.4 (±11.9).
2002 Abou-Auda [27]
5 regions in Saudi Arabia
and other Gulf countries
(Kuwait, U.A.E., Qatar,
and Oman)
A questionnaire was administered to a total
of 1641 households participated in the study
(1554 in Saudi Arabia; 87 in other countries).
Survey study.
A total of 12,463 drug products
were found in 1554 households
in Saudi Arabia. Among the 87
households surveyed in the 4
other Gulf countries, 616 drug
products were found.
Not studied.
2011 Kheir et al. [51] Qatar
This was a cross-sectional, exploratory,
descriptive study. Households included in
the study were identified using a list of
home telephone numbers was selected
randomly from the telephone directory
maintained by Qtel®, Qatar’s national
telephone company.
Survey study.
Four hundred and thirty-two
phone calls were made to
invite respondents to take part
in the study. Eighty-one
household representatives
initially expressed interest in
being part of the research
during the first call, of whom
49 participants (18% of the
targeted sample size) answered
all survey questions.
Not reported.
Pharmacy 2020, 8, 230 15 of 37
Table A1. Cont.
Year of Study Author(s) Country/Settings Research Instrument
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Campaigns vs. Survey)
Sample Demographics
2007 Al-Siyabi et al. [60]
Oman; Sultan Qaboos
University Hospital
(SQUH)
Observational study of returned unused
medicines to the pharmacy at SQUH
between February and June 2003.
Returned medicines received
by pharmacy staff were
analysed in the study.
A total of 1171 items
(medications) were returned to
the pharmacy at SQUH; among
these, 99 drugs were excluded.
Medicines were included only
if they had SQUH patients’
labels, and any items without
SQUH patient’ labels were
excluded from study.
Not studied.
2004 Wongpoowarak et al. [20] Thailand; Songkhla
A cross-sectional survey of unused
medicines of a random sample of 931
households in the Songkhla. Of the 931
households surveyed and interviewed by
using a structured questionnaire, there were
453 (48.7%) where at least one person
reported having unused medications.
Survey study.
A total of 1004 unused
medication (items) were
identified from 523
respondents who had unused
medications in 453 households.
Nine items could not be
identified because their
physical appearance did not
match that of any known
medication. Thus, 995 items
were included.
Gender:
Male: 224 (42.8%).
Female: 299 (57.2%).
Age:
0–9 years: 167 (31.9%).
10–19 years: 52 (10.0%).
20–29 years: 66 (12.6%).
30–39 years: 76 (14.5%).
40–49 years: 64 (12.2%).
50–59 years: 40 (7.7%).
≥60 years: 58 (11.1%).
2013 Sooksriwong et al. [50]
Thailand; 4 regions of
Thailand: Bangkok,
Chiang Mai, Khon Kaen,
Mahasarakham and
Songkla
Structured questionnaire developed to
survey 357 households which were
interviewed and during January and March
2011: 46% in Bangkok and 54% in
upcountry.
Survey study.
2208 drug items were found in
357 households. 952 items
(43%) of these drug items were
dispensed by public hospitals,
750 items (34%) were from
drug stores, 163 items (8%)
were from private hospitals
and 210 items (10%) were from
others.
Not studied.
2011 El-Hamamsy [26] Egypt; Cairo
Pilot study where all drugs returned unused
to 20 community pharmacies in Cairo over
period of one month (April 2009).
All drugs returned unused
to 20 community pharmacies
located in Cairo, Egypt were
documented during April
2009.
A total of 316 patients
completed a survey about
medication disposal
practices.
A total of 541 drugs were
returned and collected over
one month.
Not studied.
2012 Ibrahim et al. [49] Egypt; Alexandria
A cross-sectional descriptive study where all
drugs returned unused into randomly
selected 60 pharmacies in Alexandria over a
period of one month during March 2011.
Survey study.
A total of 657 drugs were
returned from 600 patients to
the 60 pharmacies over one
month.
Males constituted the
higher percentage of the
participants 56.7%.
Elderly having 60 years
or above constituted the
highest proportion of the
sample (28.3%), while the
lowest percentage (4.0%)
was within the age group
(10 to less than 20).
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Wasted Medicines
Information (e.g., Take Back
Campaigns vs. Survey)
Sample Demographics
2010 Guirguis et al. [32] Australia; St Vincent’sHospital, Melbourne
Retrospective audit looked at all expired
medications or those no longer needed were
collected at St Vincent’s Hospital,
Melbourne over 2 months (July and August
2008).
Retrospective audit looked
at all the items collected over
a period of 2 months: July
and August 2008.
A total of 293 items were
collected from 40 patients
recruited over 2 months.
Older than 65 years of
age.
2014 Kagashe et al. [57]
Tanzania; tertiary
hospital in Dar
ES-Salaam city
Cross-sectional study carried out at a
tertiary hospital in Dar es Salaam city
Tanzania where patient files were analysed
for last admission treatment information for
the year 2012.
Survey study.
About 56.3% of medicines
prescribed were dispensed to
patients. Out of the total 1418
dispensed drugs, 730
medicines were wasted.
The mean age of the
study population was
44 years, with minimum
age of 11 years and
maximum of 88 years.
Medicines wastage was
reported from female
more than in male (404
(55.7%) vs. 326 (47.1%),
respectively).
2007 Abahussain et al. [33] Kuwait; Kuwait city Municipal collection program of unwantedmedicines from households in Kuwait City.
Take back collection
program.
Sample of 200 households in
Kuwait received an
educational letter and special
plastic bags in which to place
unwanted medicines to be
collected by the municipality.
A second convenience sample
of an additional 14 households
in Kuwait received the same
educational letter together with
a face-to-face interview and
assistance in collecting
unwanted medicines.
Not studied.
2013 Aditya [43] India; dental hospital inNorth India
Descriptive cross-sectional survey of dental
students based on a structured
questionnaire format) was carried out in a
teaching dental hospital in North India.
Survey study.
244 students, with 8 students
were excluded due to
incomplete forms only 236
were included.
Age of participants from
20 to 40 years.
2011 Gupta et al. [42] India; Greater Noida City
A simple randomised prospective survey
study that was carried out for a period of six
months in selected areas of Greater Noida
City. Randomly selected 102 houses were
visited to educate and assess the people
about Home Medicine Cabinet.
Survey study.
A total of 392 people were
surveyed in 92 houses with the
exception of 10 houses.
Of the total 392 people
surveyed:
The male vs. female for
those with age >12 years
is 144 (36.73%) vs.133
(33.93%), respectively.
The male vs. female for
those with age <12 years
is 69 (17.6%) vs. 46
(11.74%), respectively.
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2014 Mirza and Ganguly [44] Anand district of Gujarat,India
A cross-sectional study was conducted
during 2012–2014. Data were collected from
800 houses, 400 each from urban and rural
areas and then analysed for the details of
medicines available in the house.
Survey study.
A total of 800 houses, 400 each
from urban and rural areas,
were included for the study,
which was based on the
prevalence of self-medication
as per a previous study done in
India.
The participants above
the age of 18 years,
capable of giving
information of medicine
use within the family (the
heads of the households
or their spouses or any
adult capable of
delivering required
information) were
interviewed for the study.
The presence of any
healthcare professional
amongst the family
members in a visited
house was excluded in
order to avoid biased
answers.
2009 Ali et al. [24] Malaysia; Universiti Sains
A prospective descriptive, cross-sectional
survey was conducted from February to
June 2005 in the Universiti Sains, Malaysia.
Survey study.
A total of 481 single female
respondents were targeted for
a questionnaire-based survey
on randomly sampled students.
A total of 1724 different types
of medicines were found with
an average number of 4
medicines found per student.
Respondent were only
females ages varied from
19 to 54 years old. 89.2%
(n = 429) of the students
were categorised in the
19–24 years age category,
while 8.7% (n = 42) were
aged between 25 and 30
years old. The remaining
2.1% (n = 10) were aged
between 31 and 54 years.
2020 Hassali and Shakeel [45] Selangor, Malaysia
The quantitative, cross-sectional study was
conducted by face-to-face interviews using a
pre-validated structured survey form in
Selangor, Malaysia from September to
December 2019.
Survey study.
Among the approached 600
individuals, 426 showed their
willingness to participate in the
study.
Hence, the response rate of the
present study was 71%.
A large proportion of the
respondents (269; 63.1%)
were females. Most of the
respondents were Malay
(378; 88.7%), followed by
Chinese (32; 7.5%).
The study population
included students,
private and public sector
employees, and
housewives, who were
over 18 years of age.
More than half of the
respondents were
bachelor’s degree holders
(220; 51.6%).
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2014 Aboagye et al. [59] Ghana
The study was conducted over selected
areas in Ghana with a questionnaires were
randomly issued out from 13 to 20
December 2009.
Survey study.
Out of the 200 questionnaires
sent out, 180 were retrieved
and analysed.
The majority of the
respondents 62.8%
(113/180) were between
the ages of 21 and 40
years, and the minority
5.6% (10/180) were above
61years. A total of 99
(55%) of the respondents
were males
corresponding to 81 (45%)
females.
2019 Huang et al. [52]
China, six provinces in
North, Central, and
Southern regions of
China
A cross-sectional survey of 625 households
survey was carried out between March and
April 2018 in China.
Survey study.
We randomly sampled 1000
households from the
communities
according to community
population information
registration forms. At the end
of the period, after removal of
incomplete responses, a total of
625 completed and usable
questionnaires were received,
equating to a response rate of
62.5% (625/1000).
The majority of
respondents, 61.9%
(387/625) in the
households visited were
females. A high
proportion 60.6%
(379/625) of the
respondents were
employees from different
companies. In terms of
age groups, 78.4%
(490/625) of respondents
were less than 30 years
old, and 12.0% (75/625) of
the respondents were
aged between 31 and 45.
2019 Vella and West [58] Malta, Maltese village
The study was conducted from 1 April to 31
December 2018 within a community
pharmacy in a small Maltese village with
3500 inhabitants.
Survey study.
A total of 411 medications were
collected, amounting to a total
cost of approximately €2600.
Not reported.
2020 Insani et al. [54] Bandung, Indonesia
A descriptive cross-sectional study was
conducted in Bandung, Indonesia, from
November 2017–January 2018.
Survey study. A total of 497 respondentscompleted the questionnaire.
A total of 497
respondents completed
the questionnaire of
which many were female
(n = 366, 73.6%) and aged
between 18 and 30 years
(n = 424, 85.3%). More
than half of them
completed secondary
education (n = 326, 65.6%)
and about one-third (n =
167, 33.6%) were
university graduates. A
large proportion of
respondents were
students/university
students (n = 342, 69.0%).
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2010 Jassim [53] Basrah, Iraq
This is a descriptive study involving a
questionnaire survey to determine the
extent of drug storage and self-medication
in 300 household units Basrah, Iraq between
2007 and 2008.
Survey study.
A total of 300 household units
in Basrah, Iraq included in this
study. A survey was conducted
in 300 households in Basrah,
southern Iraq to determine the
availability, source, and storage
conditions of medicinal drugs
and the prevalence of
self-medication with
antimicrobials.
Not reported.
2012 Auta et al. [55] Nigeria
A cross-sectional survey of a random
sample of 240 undergraduate pharmacy
students of the University of Jos, Jos,
Nigeria, was carried out.
Survey study.
A total of 240 students were
chosen randomly with at least
50 from each professional
level/year to participate in the
study. A pre-tested,
self-administered
questionnaire was distributed
among participants after
explaining the purpose of the
study and obtaining oral
informed consent.
A total of 188 of the 240
(representing 78.3%)
questionnaires
administered were
completely filled and
returned by respondents.
The respondents
consisted of 55.3% males
and 44.7% females with
the majority of the
respondents between the
ages of 21 and 25 years.
2015 Wondimu et al. (41) Tigray Region, NorthernEthiopia
A community-based cross-sectional study
was conducted in April 2013 in Tigray
Region, Ethiopia.
Survey study.
A total of 1034 participants
were enrolled in the study. A
multi-stage sampling method
was employed to select
households.
Overall, 1000 (97%)
households responded to
the interview, among
them 504 urban and 496
were rural. The median
family size of the
households was 5; just
above half (52%) of the
households had at least
five family members.
Only 7% of the surveyed
households had a health
professional as a family
member.
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2017 Teni et al. [36] Gondar town,northwestern Ethiopia
A cross-sectional household survey was
conducted from 5 April to 6 May 2015. In
the study, 809 households were surveyed
from four sub-cities selected through
multi-stage sampling with 771 included in
the final analysis.
Survey study.
In the study, 809 households
were surveyed from four
sub-cities selected through
multi-stage sampling with 771
included in the final analysis.
Of the participants of the
study that represented
their respective
households, upwards of
three quarters (76.3%)
and two-fifths (40.9%)
were female and those in
the age group of 18 to 29
years, respectively.
Nearly three-fourths
(73.3%) followed
Orthodox Christianity,
and almost all (90.3) were
Amhara in their ethnic
identity.
2019 Ebrahim et al. [37] Awi zone, Amhararegional state, Ethiopia
A facility-based cross-sectional study design
supplemented by a qualitative approach
was conducted from 23 April to 22 May
2018.
Survey study.
A total of 4 health facilities
were included in the study.
During the 1 month of the
study period, 56 types of
medications were found
unused at the health facilities.
Three of the heads were
male and one was a
female. All of them were
BSc nurses with a work
experience of a minimum
of 4.6 and a maximum of
8 years. All the pharmacy
heads were male and
degree holders with a
minimum experience of 4
years and maximum
experience of 8 years. A
total of 3 store women
and 1 store man were
interviewed. All the store
men/women were
diploma holders with a
work experience of a
minimum of 4 years and
a maximum of 8 years.
2020 Gudeta and Assefa [39] Jimma city, Ethiopia
A facility-based descriptive cross-sectional
study was conducted among private
practitioners in retail outlets of Jimma city
from 20 November to 19 December 2018.
Survey study.
All drug shops, 35 (62.5%) and
pharmacies, 21 (37.5%) in
Jimma city, were visited, 3 of
which were used for
pre-testing. A total of 106
questionnaires were
distributed to practitioners in
53 retail outlets, of which 87
returned the completed
questionnaires, making a
response rate of 82.1%.
The majority of the
practitioners, 44 (50.6%)
were within the age range
of 25 to 31 years. More
than half, 56 (64.4%) of
them were males.
Regarding their
profession, the majority
of them were pharmacy
professionals, 73 (83.9%).
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2020 Kahsay et al. [40] Adigrat city, Ethiopia
A cross-sectional study was conducted
using semistructured questionnaires, which
focussed on knowledge, attitudes, and
disposal practices for unused and expired
medications were used to collect data from
respondents.
Survey study.
The study was conducted
among 359 respondents from
the residents of Adigrat city,
Ethiopia. All of the 359
returned questionnaires were
valid for data entry and
analysis.
All the approached 359
individuals agreed to
participate in the study.
Of the 359 respondents,
207 (57.7%) were males.
The majority (137; 38.2%)
of the respondents were
32 years old and above.
Concerning their
educational level, one
hundred and twelve
(31.2%) respondents
completed secondary
education, 178 (49.6%)
had a college/university
degree and above, and 31
(8.6%) were illiterate.
2020 Yimenu et al. [38]
Awi zone, Amhara
regional state,
Northwestern Ethiopia
A community-based cross-sectional study
was conducted through interviews with
representatives of households.
Survey study.
A total of 23 kebeles (the
smallest an administrative unit
in Ethiopia) (2 urban and 21
rural kebeles) from four
woredas were selected using a
multi-stage sampling
technique. A total of 507
households were included in
the study.
The majority of the study
participants, 368 (72.6%),
were female. The mean
age of the study
participants was 40 years,
and the majority were
between the ages of 30
and 65 (67.9%)
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2015 Gracia-Vásquez et al. [61] Mexico; nine cities ofMonterrey
The most commonly returned medications were of
nonsteroidal anti-inflammatory followed by cardiovascular
drugs. Nonsteroidal anti-inflammatory drugs: 16.11%.
Cardiovascular drugs: 14.21% (Anti-hypertensive 55%).
Gastrointestinal drugs 11.43%. Antibacterial drugs: 10.05%.
Respiratory system drugs: 8.75%. Neurological drugs:
6.13% (anti-depressant: 34%). Dietary supplement: 5.23%.
Anti-diabetic drugs: 4.34%. Miscellaneous drugs: 3.79%.
Hypolipemic drugs: 3.67%. Anti-parasitic drugs: 2.48%.
Hormonal drugs: 1.89%. Anti-micotic drugs: 1.84%.
Steroidal anti-inflammatory drugs: 1.72%. Dermatological
drugs: 1.71%. Ophthalmic drugs: 1.64%. Anti-viral drugs:
1.53%.
The majority of unused/expired
medications collected (73%) was in
solid dosage form (tablets, capsules,
granules, powders, and lozenges).
20% were liquid pharmaceutical
forms (syrups, injections, eye drops,
suspensions, emulsions, and lotions).
6% were semisolid (ointments,
creams, gel, paste, and suppositories).
1% were other forms, such as
metered dose inhalers, sprays,
patches, strips, and chewing gums.
Unable to describe
respondent demographic
information.
2008 Braund et al. [21] New Zealand
The most commonly returned medications were of the
nervous system drugs, followed by alimentary tract and
metabolism. Nervous system drugs: 17%. Alimentary tract
and metabolism system drugs: 14%. Cardiovascular system
drugs: 12%. Respiratory system and allergies: 11%.
Musculoskeletal system drugs: 11%. Infections—agents for
systemic use: 9%. Blood and blood-forming organs: 8%.
Oncology agents and immunosuppressants: 6%.
Genitourinary system: 5%. Dermatologicals: 3%. Sensory
organs: 2%. Hormone preparations—systemic: 2%.
Only oral dosage form reported. Small number of returnedunused medication.
2007 Braund et al. [67] New Zealand; OtagoPharmacies
The returned medications were not classified by therapeutic
group, but by generic name. The most commonly returned
tablet was paracetamol (9% of all tablets returned). The
most commonly returned capsule was omeprazole 20 mg
(8% of capsules); additionally, omeprazole 40 mg accounted
for a further 5% of all capsules.
There were 65,907 tablets returned
and 7599 capsules returned.
Others include injections, inhalers,
eye drops, creams, gels, ointment,
test strips, liquids, and suppositories.
Unable to describe
respondent demographic
information.
Unable to report unused
medicines as therapeutic
group.
2009 Braund et al. [31] New Zealand; Hutt ValleyDistrict Health Board
The predominant therapeutic group was drugs affecting the
nervous system, but individually, diclofenac sodium and
ibuprofen were the most returned medications, respectively.
Nervous system drugs: 19%. Alimentary tract and
metabolism: 13%. Cardiovascular system: 12%.
Musculoskeletal system: 11%. Respiratory system and
allergies, and miscellaneous: 8%. Blood and blood-forming
organs: 7%, Dermatological and anti-infective: 7%.
Genitourinary: 3%, Hormones: 3%.
Oral solid forms (tablets and
capsules) were counted. Liquid
medications were quantified by the
amount left in the original container,
semisolid preparations were
estimated as a proportion of original
container. Inhalers were recorded as
either full, half-full, or empty.
Anything almost empty was
excluded from the analysis.
The chosen sample of the
total returned unused
medicine was around
20%, which maybe not
representative of the
whole sample.
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2010 Caroline et al. [29] New Zealand; NelsonBays region
The most common returned (top 20) by quantities
(individual unit) were (n = 435,397): Salazopyrin: 94,271
tablets. Paracetamol: 23,251 tablets. Lactulose: 11,324 mL.
Aspirin: 10,047 tablets. Simvastatin: 7380 tablets.
Diclofenac: 7014 (mixed preparation). Prednisolone: 7004
tablets. Metoprolol: 6627 tablets. Warfarin: 6590 tablets.
Furosemide: 6117 tablets. Lemnis fatty cream: 6095g.
Cilazapril: 5687 tablets. (Paracetamol and codeine)
preparation: 5003 tablets. Ibuprofen: 4873 tablets. Codeine:
4794 tablets. Laxsol: 4267 tablets. Morphine: 4107 (mixed
preparations). Emulsifying ointment: 4030 g. Quinapril:
3890 tablets.
Oral solid forms (tablets and
capsules) with tablets as the most
common returned dosage form.
Oral liquid forms.
Cream and ointment.
Unable to describe
respondent demographic
information.
2009 James et al. [65]
New Zealand: Taranaki
region (around 37,000
households)
The predominant therapeutic group was drugs affecting the
nervous system, but individually, paracetamol
(acetaminophen) was the most returned medication
respectively. Nervous system drugs (n = 658, 24.3%).
Cardiovascular system (n = 559, 20.7%). Alimentary tract
and metabolism (n = 529, 19.6%). Blood and blood-forming
organs (n = 283, 10.5%). Respiratory system and allergies (n
= 190, 7.1%).
Not studied.
Unable to describe
respondent demographic
information.
In addition, due the
different policies for
collection and disposal of
medicines, the majority of
unused medicines were
disposed into landfills
and water system, which
may mean that the
returned amount may be
underestimate of the
extent of unused
medicines.
2005 Langley et al. [62] United Kingdom; EastBirmingham
The predominant therapeutic group was drugs affecting
cardiovascular system. Cardiovascular system drugs:
28.5%. Central nervous system drugs: 18.8%. Respiratory
system drugs: 14.7%. Gastrointestinal drugs: 10.6%.
Endocrine system drugs: 5.6%. Musculoskeletal and joint
disease drugs: 5%. Anti-infective Drugs: 4.7%. Eye Drugs:
3.5%. Nutrition and blood drugs: 2.1%. Skin drugs: 1.8%.
Obstetrics, gynaecology, and urinary tract disorders: 1.5%.
Nutrition and blood and unknown: 1.2%. Malignant
disease and immunosuppression: 0.9%.
Tablet or capsule, oral liquid, cream
or ointment, and inhalers.
Sample size and the
number of returns are
small, which makes it
difficult to extrapolate the
result to the whole United
Kingdom.
Pharmacy 2020, 8, 230 24 of 37
Table A2. Cont.
Year of Study Author(s) Settings/Country Therapeutic Category of the Unused, Wasted Medicine Dosage Form Study Limitation
2007 Mackridge et al. [63]
United Kingdom; Eastern
Birmingham Primary
Care Trust (P.C.T.)
The predominant therapeutic groups were drugs affecting
cardiovascular system and drugs acting on the central
nervous system, respectively. The most commonly returned
drugs were aspirin (102 items), co-codamol (98 items),
salbutamol (96 items), furosemide (90 items), and glyceryl
trinitrate (78 items). Drugs affecting cardiovascular system
(1003 items, 26.6%). Drugs acting on the central nervous
system (884 items, 23.5%). Drugs affecting respiratory
system (358 items, 9.5%) and gastrointestinal system (358
items, 9.5%). Drugs affecting endocrine system (257 items,
6.8%). Drugs treating musculoskeletal and joint diseases
(235 items, 6.2%). Anti-infective drugs (165 items, 4.4%).
Drugs for skin (124 items, 3.3%). Drugs for nutrition and
blood (116 items, 3.1%). Drugs for eye (65 items, 1.7%).
Obstetrics, gynaecology, and urinary tract disorders (59
items, 1.6%). Drugs for ear, nose, and oropharynx (58 items,
1.5%) and others (58 items, 1.5%). Drugs for malignant
disease and immunosuppression 20 items, 0.5%). Drugs for
anaesthesia (5 items, 0.1%).
Tablet or capsule, oral liquid, cream
or ointment, and inhalers.
The author reported that
this study did not attempt
to estimate the quantities
of unused medicines at
patient’s home; as a result,
it is more likely that the
unused medicines from
primary care was
underestimated.
2008 Bradley [64] United Kingdom;Cumbria
The greatest value of returned of medicines was from
cardiovascular and central nervous system categories
(BNF), total number of returns (n = 4562): Cardiovascular
(n = 1232). Central nervous system (n = 1149).
Gastrointestinal system (n = 468) Endocrine (n = 334).
Respiratory (n = 307). Anti-infective (n = 250).
Musculoskeletal and joint (n = 228). Nutrition and blood (n
= 141). Skin (n = 134). Others (n = 319)
Not studied.
It is an audit report with a
result from
Cumbria/northwest of
England, which may not
representative of the
whole United Kingdom
and may underestimate
the extent of unused
medicines.
2010 Trueman et al. [6] United Kingdom
Coding was based on guidance provided by the Royal
Pharmaceutical Society of Great Britain/BNF. The most
common retuned medication was for the cardiovascular and
central nervous system. Cardiovascular system drugs (1950
items, 22.6%). Central nervous system drugs (1907 items,
22.11%). Gastrointestinal system drugs (828 items, 9.6%).
Respiratory system drugs (528 items, 6.12%). Endocrine
system drugs (518 items, 6.01%). Endocrine system drugs
(518 items, 6.01%). Anti-infective drugs (444 items, 5.15%).
Musculoskeletal, joint disease drugs (364 items, 4.22%).
Nutrition and blood drugs (249 items, 2.89%). Skin drugs
(192 items, 2.23%). Eye drugs (129 items, 1.5%). Ear, nose,
oropharynx drugs (68 items, 0.79%). Malignant disease and
immunosuppression drugs (53 items, 0.61%). Wound
management drugs (34 items, 0.39%). Borderline substances
(25 items, 0.29%). Drugs for Anaesthesia (9 items, 0.10%).
Not studied.
Unable to describe
respondent demographic
information.
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2008 Coma et al. [56] Spain; Barcelona
The predominant therapeutic groups were drugs affecting
the alimentary tract and metabolism, nervous system, and
cardiovascular system, respectively. All drugs were
categorised according to Anatomical Therapeutic Chemical
(A.T.C.) system/code of the World Health Organisation
(WHO). Alimentary tract and metabolism drugs (215 items,
18.3%). Nervous system drugs (214 items, 18.2%).
Cardiovascular drugs (137 items, 11.6%). Respiratory
system drugs (103 items, 8.8%). Musculoskeletal system
drugs (88 items, 7.5%). Dermatological drugs (85 items,
7.2%). Anti-infective drugs (77 items, 6.5%). Missing drugs
(could not be coded according to the A.T.C. system), (66
items, 5.6%). Sensory organs drugs (63 items, 5.4%). Drugs
affecting genitourinary system and sex hormones (50 items,
4.3%). Drugs affecting blood and blood-forming organs (32
items, 2.7%). Antineoplastic and immune-modulating
drugs (22 items 1.9%). Systemic hormonal preparations
excluding sex hormones and insulins, (17 items, 1.4%).
Various drugs (5 items, 0.4%). Anti-parasitic products,
insecticides, and repellents (2 items, 0.2%).
Not studied.
Unable to describe the
respondent demographic
information clearly.
2015 Law et al. [46] U.S.A.; SouthernCalifornia
Approximately 2 of 3 prescription medications were
reported unused. In Phase I, pain medications (23.3%) and
antibiotics (18%) were most commonly reported as unused.
In Phase II, 17% of medications for chronic conditions
(hypertension, diabetes, cholesterol, heart disease) and 8.3%
for mental health problems
(antidepressants/antipsychotic/anti-convulsant) were
commonly reported as unused. 7% painkillers and 4%
electrolytes and dietary supplements.
Tablets, pills, capsules, and liquid
preparations.
Use of a web-based survey
may limit the accessibility
of this study to people
without computer and
Internet access at home,
which may to some extent
underestimate the extent
of unused medicines.
Unable to describe
respondent demographic
information.
2004 Garey et al. [25] U.S.A.; Houston, Texas
The predominant therapeutic group was nonsteroidal
anti-inflammatory drugs/pain. Nonsteroidal
anti-inflammatory drugs/pain 25%. Drugs for
cough/cold/allergy 15%. Anti-infective drugs 11%.
Cardiovascular drugs 10%. Respiratory drugs 9%.
Neurological drugs 8%. Dermatological 7% and
gastrointestinal 7%.
Oral medications (capsules or tablets)
were most commonly returned (64%),
followed by liquid (12%), creams
(11%), inhalers (7%), or miscellaneous
(6%; e.g., eye glasses, hearing aid
batteries, medical equipment).
Approximately 17,000 oral pills were
collected during the study period.
Unable to describe
respondent demographic
information.
2016 Maeng et al. [34]
U.S.A.; Regional health
plan in Central
Pennsylvania
The predominant therapeutic group was pain medication
(15%), hypertension (14%), antibiotics (11%), and
psychiatric disorders (9%).
Not studied.
Unable to describe
respondent demographic
information.
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2014 Vogler et al. [66] Austria; Vienna
The predominant therapeutic group was cardiovascular
drugs. Cardiovascular drugs (36 packs, 23.7%).
Musculoskeletal system drugs (17 packs, 11.2%). Nervous
system drugs (16 packs, 10.5%) Alimentary tract and
metabolism 15 packs, 9.9%). Anti-infective drugs for
systemic use (5 packs, 3.3%). Drugs for blood and
blood-forming organs (4 packs, 2.6%). Genitourinary
system drugs and sex hormone (2 packs, 1.3%) and
Dermatological drugs (2 packs, 1.3%). Other A.T.C. code or
not attributable (45 packs, 29.6%).
Oral medications were the most
commonly founded 86.8% (usually
solid oral), followed by dermal 6.7%,
parental 4%, nasal 0.7%, pulmonary
0.7%, eye 0.7%, and dental 0.7%.
Unable to describe
respondent demographic
information.
2013 Chien et al. [71]
Taiwan; Shuang-Ho
university teaching
hospital
Among the discarded medications, gastrointestinal drugs
were at the top of the list of all discarded medications. The
analysis of discarded and unused drugs revealed that
Strocain (oxethazaine, polymigel) was on top of the list,
followed by Glucobay (acarbose), Mopride (mosapride),
and Loditon (metformin). Gastrointestinal drugs: 25.93%.
Cardiovascular drugs: 22.49%. Anti-inflammatory drugs:
12.15%. Anti-diabetic drugs: 9.49%. Cold medicines: 6.83%.
Psychiatric drugs: 5.44%. Respiratory drugs: 2.16%.
Rheumatological drugs: 1.52%. Antimicrobial drugs: 1.42%.
Others: 9.19%. Health foods: 3.38%.
Tablets, bottles, and tubes.
Unable to describe
respondent demographic
information.
2013 Abushanab et al. [48] Jordan; Amman
Alimentary tract and metabolism drugs were the most
commonly found in household (both used and unused).
Stored drug products were classified by A.T.C. code of
WHO. Alimentary tract and metabolism: 519 (20.7%).
Nervous system: 370 (17.3%). Musculoskeletal system: 313
(12.9%). Respiratory system: 291 (12%). Cardiovascular
system: 256 (10.9%). Anti-infective for systemic use: 252
(10.6%). Dermatological: 149 (5.4%). Blood and
blood-forming organs: 109 (4.6%). Genitourinary system
and sex hormones: 31 (1.1%). Systemic hormonal
preparations, excl. sex hormones and insulin: 18 (1.1%).
Anti-parasitic products, insecticides and repellents: 13
(0.7%). Anti-neoplastic and immune-modulating agents 8
(0.3%), sensory organs 63 (2.5%).
Not studied.
Studied the medication
stored at home the
estimated the unused
wasted medicine as the
sum of drug products that
had expired, had no clear
expiration date, or which
had never been used since
dispensing. So not
directly investigate the
unused wasted medicine.
2012 Al-Azzam et al. [47] Jordan; North of Jordanparticularly Irbid
Central nervous system drugs were found to be the most
common, followed by anti-infective agents. The most
common individual medications found were amoxicillin,
paracetamol, metronidazole, antihistamines,
hypoglycaemic medications, and adult cold medications.
Central nervous system drugs (713 items, 25.2%).
Anti-infective agents (493 items, 17.4%). Musculoskeletal
agents (381 items, 13.4%) Respiratory system agents (348
items, 12.3%) Gastrointestinal agents (301 items, 10.6%)
Cardiovascular agents (216 items, 7.6%) Endocrine system
agents (200 items, 7.0%) Nutrition agents (127 items, 4.5%).
Eye, ear, nose and skin agents (56 items, 2.0%).
Tablets (1794 items, 63.3%)
Capsules (332 items, 11.7%)
Syrups (250 items, 8.8%)
Suspensions (201, 7.1%)
Suppositories (117 items, 4.1%)
Creams/ointments/gels (43 items,
1.5%)
All forms of injections (53 items, 1.9%)
Drops/nasal or oral puff (45 items,
1.6%).
A sample was selected
from northern Jordan,
which may not
representative of the
whole of Jordan.
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2002 Abou-Auda [27]
5 regions in Saudi Arabia
and other Gulf countries
(Kuwait, U.A.E., Qatar,
and Oman)
Medications were also categorised according to their
pharmacologic or therapeutic class using the classification
of drugs adopted in the Saudi National Formulary (SNF).
Respiratory system drugs Saudi Arabia: 2095 (16.8%), other
gulf countries: 94 (15.3%). Central nervous system drugs
Saudi Arabia: 2050 (16.4%), other gulf countries: 84 (13.6%).
Antibiotics Saudi Arabia: 1779 (14.3%), other gulf countries:
111 (18.0%). Gastrointestinal drugs Saudi Arabia: 1382
(11.1%), other gulf countries: 60 (9.7%). Miscellaneous
Saudi Arabia: 847 (6.8%), other gulf countries: 57 (9.3%).
Nutrition and blood drugs Saudi Arabia: 823 (6.6%), other
gulf countries: 24 (3.9%). Musculoskeletal/joints drugs
Saudi Arabia: 790 (6.3%), other gulf countries: 52 (8.4%).
Skin drugs Saudi Arabia: 735 (5.9%), other gulf countries:
33 (5.4%). Ear, nose, and throat drugs Saudi Arabia: 553
(4.4%), other gulf countries: 26 (4.2%). Cardiovascular
drugs Saudi Arabia: 465 (3.7%), other gulf countries: 60
(9.7%). Eye drugs Saudi Arabia: 398 (3.2%), other gulf
countries: 25 (4.1%). Endocrine drugs Saudi Arabia: 375
(3.0%), other gulf countries: 16 (2.6%).
Obstetric/gynaecologic and/or urinary drugs Saudi Arabia:
140 (1.1%), other gulf countries: 12 (1.9%). Cytotoxic drugs
Saudi Arabia: 31 (0.2%), other gulf countries: 0 (0.0%). Total
drugs Saudi Arabia: 12,463 (100%), other gulf countries:
616 (100%). The mean medication wastage was estimated to
be 25.8% Saudi Arabia and 41.3% other gulf countries.
Not studied.
Unable to describe
respondent demographic
information.
2011 Kheir et al. [51] Qatar
The majority of the drugs stored (n = 58; 21%) in the
participating homes were analgesics. Nonsteroidal
anti-inflammatory drugs were the second most commonly
stored drugs, representing 16% of all the drugs.
Not reported.
There was potential for
selection and social
desirability bias as a result
of the strategy of using
the telephone to conduct
an interview. In addition,
interviews were
conducted during
working hours, which
could run the risk of
excluding highly
educated young subjects.
Due to the small sample
size, the results of this
exploratory study should
be considered with
caution.
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2007 Al-Siyabi et al. [60]
Oman; Sultan Qaboos
University Hospital
(SQUH)
Cardiovascular drugs were the most common
pharmacological group of returned drugs. The drugs were
classified according to the classification index of the British
National Formulary. Cardiovascular drugs: 24%. Central
nervous system drugs: 14%. Anti-infective drugs: 13%.
Endocrine drugs: 10%. Nutrition: 9%. Gastrointestinal
drugs: 8%, and Musculoskeletal system drugs: 8%.
Respiratory system drugs: 5%. Immunosuppressant drugs:
3%. Eye/Ear drugs: 2%.
Not studied.
Unable to describe
respondent demographic
information.
As it included only
medicines with SQUH
labels, others were missed,
and this may
underestimate the extent
of unused medicines.
2004 Wongpoowarak et al. [20] Thailand; Songkhla
Musculoskeletal system drugs were the most common
pharmacological group of returned drugs.
The medications were pharmacologically classified using
MIMS Thailand, which is a standard reference source.
Musculoskeletal system drugs (229 items, 23.3%).
Anti-infective drugs (189 items, 19.2%). Respiratory system
drugs (166 items, 16.9%). Gastrointestinal system drugs
(129 items, 13.1%). Allergy and immune system drugs (91
items, 9.2%). Vitamins and minerals (68 items, 6.9%).
Others (54 items, 5.5%). Central nervous system (37 items,
3.8%). Cardiovascular (21 items, 2.1%).
Oral dosage forms compromised
95.6% (951 items).
Oral tablets or capsules (636 items,
63.9%).
Oral liquids (311 items, 31.3%).
Eye drops (23 items, 2.3%).
Topical liquids (14 items, 1.4%).
Creams (5 items, 0.5%).
Oral powders (4 items, 0.4%).
Inhalers (2 items, 0.2%).
This study was a snapshot
study, as the studied
population was one of 14
provinces in southern
Thailand.
2013 Sooksriwong et al. [50]
Thailand; 4 regions of
Thailand: Bangkok,
Chiang Mai,
Khon Kaen,
Mahasarakham and
Songkla
A total of 2208 drug items found in household surveys were
classified into 5 groups of the mostly found drugs. These
were 343 non-opioid analgesics and antipyretic drugs, 188
antacids, anti-reflux agents and anti-ulcer, 180 nonsteroidal
anti-inflammatory drugs (NSAIDs), 127 antihistamine and
anti-allergic and 119 anti-diabetic drugs. Top 5 of the most
found rarely or unused drugs, classified as leftover
medicines, were NSAIDs (49 items), penicillin (38 items),
G.I.T. regulators, and antiflatulents (36 items).
Of the total of 2208 drug items found in household, 82 items
(3.7%) and 45 items (2.0%) of drugs were already expired
and deteriorated, respectively.
Not studied.
Unable to describe
respondent demographic
information.
2011 El-Hamamsy A [26] Egypt; Cairo
The returned medications were classified according to the
British National Formulary (BNF). Antibiotics were the
most common pharmacological group of returned
medications. Antibiotics (109 items, 20.15%).
Gastrointestinal system drugs (88 items, 16.27%).
Cardiovascular system drugs (58 items, 10.72%).
Respiratory system drugs (44 items, 8.13%). Nervous
system drugs (39 items, 7.20%). Analgesics and
anti-inflammatory (38 items, 7.02%). Dermatological drugs
(35 items, 6.47%). Blood and blood-forming organs (29
items, 5.36%). Systemic hormonal preparations, sex
hormones, and insulin’s (27 items, 4.99%). Anti-parasitic
products, insecticides, and repellents (25 items, 4.62%).
Genitourinary system (20 items, 3.69%). Antineoplastic and
immune-modulating agents (3 items, 0.55%). Various others
(26 items, 4.80%).
Not studied.
Unable to describe
respondent demographic
information.
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2012 Ibrahim et al. [49] Egypt; Alexandria
Cardiovascular system drugs were the most common
pharmacological group of returned medications. The
returned medications were classified according to the
British National Formulary (BNF). Cardiovascular system
(127 items, 19.4%). Anti-infective (126 items, 19.2%).
Gastrointestinal system (66 items, 10.9%). Nutrition and
blood (69 items, 10.6%). Nonsteroidal anti-inflammatory
(64 items, 9.8%). Nervous system (61 items, 9.3%).
Respiratory system (58 items, 8.9%). Endocrine System (49
items, 7.5%). Skin care (19 items, 2.9%). Ear, nose, throat (7
items, 1.1%) and genitourinary system (7 items, 1.1%).
Musculoskeletal system (2 items, 0.3%).
Not studied.
This study did not
estimate the quantities of
unused medicines in
patient’s home. As result,
it is likely that it may
underestimate the extent
of unused medicines in
the community.
2010 Guirguis et al. [32] Australia; St Vincent’sHospital, Melbourne
Cardiovascular system drugs were the most common
pharmacological group of returned medications. The
smallest group was that of topicals, e.g., creams and
ointments.
Cardiovascular system drugs (78 items, 26.6%).
Analgesics/anti-inflammatories (62 items, 21.2%).
Neuropsychiatry drugs (8.5%). Respiratory system drugs
(8%). Eye/Ear/Nose drugs (7.5%). Gastrointestinal drugs
(7%), and Antimicrobials (7%). Herbals and vitamins (12
items, 4.1%). Diabetes drugs (3%). Topicals, e.g., creams
and ointments (8 items, 2.7%). Miscellaneous (4.5%).
They report that they collect topicals
cream, ointment along with other
dosage forms (that was not defined).
Sample size and the
number of returns are
small, which make it
difficult to extrapolate the
result to the whole of
Australia.
2014 Kagashe et al. [57] Tanzania; tertiary hospitalin Dar es Salaam city
Medicines wasted in this study were categorised into three
major groups, anti-infective, cardiovascular medications,
and others. Anti-infective drugs: 18.9%. Cardiovascular
drugs: 8.9%. Other drugs: 23.7%.
Oral solids drugs were the most
common wasted dosage form 40.6%
followed by injections 9.2%, with
very few topicals preparations.
Since only
hospital-prescribed
medicines was included,
others may be missed,
which may underestimate
the extent of unused
medicines.
2007 Abahussain et al. [33] Kuwait; Kuwait city
No medicines were collected from the 200 households
participating in the municipal collection program The
second intervention yielded 123 medicines from 14 homes;
the most common class of unwanted medicines were drugs
for respiratory system. Unwanted medications were
classified according to the ATC WHO classification.
A third of all unwanted medicines were for the respiratory
system (38% of these were cough and cold preparations,
25% nasal preparations). 12% of the medicines were for the
musculoskeletal system (53% oral NSAIDs) or were
dermatologicals (33% topical antibiotics).
There were 141 items (including
duplicates). 508 tablets/capsules, 25
oral liquids, 20 tubes, 21 dropper
bottles, and various other dosage
forms.
Sample size and the
number of returns are
small, which make it
difficult to extrapolate the
result to the whole of
Kuwait.
Unable to describe
respondent demographic
information.
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2013 Aditya [43] India; dental hospital inNorth India
Qualitative analysis of expired medications at home
revealed antipyretics (54%), analgesics (64%), followed by
antihistamines (35%) to be hoarded in home
pharmacies/medicine chests. Other drugs were antibiotics
(26%), antacids (23%), topical drugs (39%) and supplements
(vitamins) (41%). Excessive buying of over-the counter
(O.T.C.) drugs (53%); self-discontinuation (17%), and
expiration of drugs (24%) resulted in possession of
unused/leftover medications at home.
Not studied.
Small sample size from a
specific region in India,
which make it difficult to
generalise and extrapolate
the results to the whole of
India.
2011 Gupta et al. [42] India; Greater Noida City
Most of the expired drugs are in the category of analgesics
and NSAIDs (23.93%) followed by nutritional supplements
(22.56%), antibiotics (14.94%), expectorants and mucolytics
(6.77%), bronchodilators (5.31%), and antacids (6.53%).
Oral tablets were the most common;
other dosage forms include syrups,
capsules, suspensions, powders, eye
drops, gels, churna, cream, and ear
wax softener.
Defined medicine wastes
as only expired medicines,
which may underestimate
the extent of unused
wasted medicines.
2014 Mirza and Ganguly [44] Anand district of Gujarat,India
Among the prescribed medicines, the majority of medicines
were from cardiovascular disease (19.88%) and from
without prescription medicines, nonsteroidal
anti-inflammatory drugs (NSAIDs) were the major group
available at houses (35.13%).
Not reported.
Since the interviewers
were fully aware of the
purpose of the project,
some information
regarding medicines was
not shared, which might
have led to a skewed
result.
2009 Ali et al. [24] Malaysia; Universiti Sains
The total number of medicines found unused was 1724
drug products with vitamins and minerals as the most
common class of unused drugs. Vitamins and minerals: 427
(24.8%). Gastrointestinal drugs: 298 (17.3%). Analgesic and
antipyretics: 293 (17.0%). Antibiotics: 174 (10.0%). Ear,
nose, and throat drugs: 159 (9.2%). Respiratory drugs: 106
(6.3%). Dermatological products: 97 (5.6%). Anti-rheumatic
and anti-inflammatory: 69 (4.0%). Others (C.N.S. drugs,
endocrine and metabolic drugs, cardiovascular drugs,
genitourinary drugs, and others): 101 (5.8%).
68.5% (n = 1181) of the medications
were in the form of tablets and pills
while capsules constituted 14.6% (n =
252) of the overall amount. 5% (n =
87) syrups and suspensions while
4.9% (n = 84) were creams and
ointments.
Less than 1.0% (n = 5) consisted of
inhalers, with 0.2% (n = 4)
suppositories of the overall total.
Sampling of only female
students made it
impossible to generalise
the results to the whole
student population in the
campus.
2020 Hassali and Shakeel [45] Selangor, Malaysia
The major classes of medications that were purchased
included antibiotics (207; 48.5%) followed by
painkillers/nonsteroidal anti-inflammatory drugs (NSAIDs)
(101; 23.7%). In addition, anti-hypertensive 51 (11.9%),
anti-diabetic 20 (4.6%), OTC antihistamines 34 (7.9%), and
multi-vitamins and other supplements 13 (3.0%).
Not studied.
The sample size of the
study was small to depict
a clear picture of the entire
Selangor population;
hence, the findings of the
current study are not
generalisable to all of
Malaysia.
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2014 Aboagye et al. [59] Ghana
Leftover medicines:
Paracetamol tablets 27
Amoxicillin capsules 12
Aspirin tablets 4
Metronidazole tablets 5
F-PAC (Paracetamol/Aspirin/Caffeine) 3
Vitamin B complex tablets 7
Multi-vitamins tablets 7
Diclofenac tablets 3
Magnesium trisilicate tablets 3
Ibuprofen tablets 5
Others/Unidentified 45
Do not remember 1.
Not studied.
Sample size and the
number of returns are
small which make it
difficult to extrapolate the
result to the whole of
Ghana.
Leftover medicines were
described as individual
medicine, not as a group.
2019 Huang et al. [52]
Six provinces in North,
Central, and Southern
regions of China
Cold medication (86.1%) was the most common category of
medicines kept in households. Specifically, the following
were the major classes of medicines found in the
households: gastrointestinal medicines (27.0%), pain
medications (22.9%), vitamins (20.6%), antibiotics (19.0%),
external painkillers (16.5%), and external anti-inflammatory
antidotes (15.4%).
Not studied. Not reported.
2019 Vella and West [58] Maltese village, Malta
The most common class of disposed medications was that
pertaining to the alimentary tract (24.6%), closely followed
by medicines belonging to the respiratory group (23.8%).
10.5% of the unused disposed medications were from the
musculoskeletal group, which includes medications such as
nonsteroidal anti-inflammatory drugs (NSAIDs), and
supplements, such as glucosamine. The medications with
the lowest return rate were anti-neoplastic and
immunomodulating agents (0.7%), followed by
anti-parasitic medications (0.2%).
Solid dosage forms were counted
manually, liquid dosage forms were
measured using a calibrated
measuring cylinder, dermatological
preparations were measured using
kitchen weighing scales, and inhalers
that had a counter were recorded as
per value available on the counter.
Unused inhalers without a counter,
eye drops, ear drops, nasal drops,
and nasal and oral sprays were not
quantified as effective entries, as their
quantities could not be safely
determined.
This study excluded some
dosage forms whilst
quantifying and costing
waste, such as eye drops,
inhalers, and nasal sprays.
Therefore, the actual cost
of waste presented in this
study is an underestimate.
2020 Insani et al. [54] Bandung, Indonesia
NSAIDs were the most common medicines left unused (n =
372) followed by vitamins and nutritional supplements (n =
215) and antibiotics (n = 171).
Not reported.
This study was conducted
in one region in Bandung
(small sample size); thus,
its generalisation for the
Indonesian population is
limited. In addition, the
predictors associated with
disposal practice were not
identified.
2010 Jassim [53] Basrah, Iraq
Overall, 4279 items of drugs were analysed. Antibiotics
were the leading household stored drugs (26.43%), followed
by antipyretic/analgesics (19.58%), and NSAIDs
(nonsteroidal anti-inflammatory drugs) (11.45%). These
drugs constituted (57%) of the total drugs stored.
Not reported.
This study was conducted
in 300 households in
Basrah, southern Iraq (i.e.,
one region in Iraq). Small
sample size.
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2012 Auta et al. [55] Nigeria
Common classes of medicines reported as leftover
medicines were analgesics (36.4%), antibiotics (33.1%), and
antihistamines (11.9%).
Respondents reported having about
318 medicines items (representing
2.56 items per student’s room) in all,
with the tablets (62.3%) being the
most common dosage form.
Followed by capsules (16.4%),
lotions/creams (11.6%), and
syrups/suspensions (6.3%).
This study was based on
the self-reported presence
of medicines in
respondents’ residence.
Therefore, it is possible
that the medicines were
under-reported or some
names of unidentified
medicines were wrongly
reported. In addition, the
sample size was small.
2015 Wondimu et al. [41] Tigray Region, NorthernEthiopia
The most common classes of drugs found in the households
were analgesics (29%) and antibiotics (25%). Generally,
more than half (62%) of the medications were used for
ongoing treatment.
Most (70%) of the medicines were
available in the form of tablets,
followed by capsules (13.2%), oral
liquid (9.9%), semisolids (2.8%),
injections (1.8%), and other dosage
forms (2.2%).
One of the study
limitations was the
cross-sectional design
employed, which might
be affected by temporal
relationship establishment
with some variables and
could not provide much
more substantial evidence
of causality, unlike a
longitudinal design.
2017 Teni et al. [36] Gondar town,northwestern Ethiopia
Anti-infectives for systemic use (23.9%), medicines for
alimentary tract and metabolism (19.2%) and those for the
cardiovascular system (17.7%) ranked top.
Of the total 553 medicines stored,
more than three quarters (80.8%)
were of solid dosage forms. Liquid
dosage forms were (16.6%) and
semisolids were (2.5%).
The study did not include
the rural parts of Gondar
Town. The small sample
size makes the findings
not representative of the
pattern of household
medicine storage practice
in those areas.
2019 Ebrahim et al. [37] Awi zone, Amhararegional state, Ethiopia
Anti-infective medications were found to be the most
frequently unused medications 63 (36.4%) followed by
antipain medications 37 (21.4%) and cardiovascular
medications 19 (11%).
Not reported.
Health centres and private
health facilities were not
included in the study, and
thus, the results may have
been slightly different if
those facilities were
included.
2020 Gudeta and Assefa [39] Jimma city, Ethiopia Antibiotics, 31 (35.6%), and anti-hypertensive, 21 (24.1%)constituted the highest proportion of the waste. Not reported.
The sample size was
small. In addition, the
current study was
conducted among private
practitioners. Thus,
prospective researchers
may consider both private
and public professionals
for their comparative
study.
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2020 Kahsay et al. [40] Adigrat city, Ethiopia
The common types of medicines kept in households were
analgesics (41.5%) and antibiotics (36.7%). In addition,
antipain and antibiotic (4.8%), anti-diabetic (5.3%), and
anti-hypertensive (8%) medicines were other types of
unused medications found in homes.
Not reported.
The small sample size and
the cross-sectional nature
of the study design
prevent us from drawing
causal inferences about
the relationship between
the chosen covariates and
outcome variables over a
period.
2020 Yimenu et al. [38]
Awi zone, Amhara
regional state,
northwestern Ethiopia
Anti-infective medicines were found to be the most
common unused medicines, 53 (58.9%), followed by
antipain medicines, 16 (17.8%).
Not reported.
The small sample size and
not including the health
centres and private health
facilities were limitations
to this study. Thus, the
results may be slightly
different if those facilities
were included.
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